Physician Wealth Advisors’s AbbVie ABBV Stock Holding History

Physician Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Buy	1,376 +74	+6%	+$15.9K	0.04%	145
2026 Q1	$283K	Buy	1,302 +66	+5%	+$14.6K	0.04%	158
2025 Q4	$282K	Buy	1,236 +276	+29%	+$62.9K	0.04%	147
2025 Q3	$222K	Buy	960 +384	+67%	+$78.2K	0.03%	179
2025 Q2	$107K	Buy	576 +66	+13%	+$12.3K	0.02%	255
2025 Q1	$107K	Buy	510 +31	+6%	+$6.03K	0.02%	245
2024 Q4	$85.1K	Buy	+479	New	+$88.1K	0.01%	275

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Physician Wealth Advisors's ABBV Position: Q2 2026 in Review

Physician Wealth Advisors increased its AbbVie (ABBV) stake by 5.7% in Q2 2026, buying an estimated $15.9K and bringing the position to 1,376 shares worth $346K. The position accounts for 0.04% of the portfolio, ranked #145.

Physician Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Physician Wealth Advisors held 1,376 shares of AbbVie worth $346K as of Q2 2026.
Physician Wealth Advisors bought 74 AbbVie shares in Q2 2026, an estimated $15.9K.
AbbVie made up 0.04% of Physician Wealth Advisors's portfolio in Q2 2026, its #145 holding.
Physician Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.